Jennifer L. Good
Co-Founder, CEO, President, & DirectorMs. Jennifer L. Good co-founded Trevi Therapeutics, Inc., in March 2011 and has been its Chief Executive Officer and President since March 2011 and had been its Interim Principal Financial Officer since August 22, 2025 until January 06, 2026. Ms. Good served as Principal Financial Officer at Trevi Therapeutics, Inc. since April 2, 2021. She serves as Independent Director at Rhythm Pharmaceuticals, Inc. since June 19, 2019. Previously, Ms. Good served at Penwest Pharmaceuticals Co. from 1997 to 2010. Ms. Good served as Chief Executive Officer and President of Penwest Pharmaceuticals Co. since June 2006 and November 23, 2005 respectively. Ms. Good served as the Chief Operating Officer of Penwest Pharmaceuticals from November 23, 2005 to June 2006; Chief Financial Officer from February 1997 to June 2006; Senior Vice President of Finance since 1997 and served as its Principal Accounting Officer and Company Secretary. She also served as Corporate Controller for Penford Corp. from 1993 to 1997. She led Penwest Pharmaceuticals Co.’s finance, human resources, corporate communications and information technology functions. Prior to joining Penwest, Ms. Good served as Corporate Controller and Corporate Director of Finance of Penford Corporation, Penwest’s former parent company, from 1993 to 1997. From 1987 to 1993, she served in a number of client management positions at Ernst & Young LLP, ultimately as audit Manager. She served as an Executive Director of Penwest Pharmaceuticals Co. since June 2006. She serves as a Director at Trevi Therapeutics, Inc. since March 2011. Ms. Good has also served as a Board Member of the Friedreich’s Ataxia Research Alliance (FARA), a patient advocacy group advancing treatments for the cure of Friedreich’s Ataxia, since 2011. She served as Director of Juniper Pharmaceuticals, Inc. since September 11, 2017 until August 14, 2018. She served as a Director of XTL Biopharmaceuticals Ltd. since October 2008. In 2007, she received the Connecticut Technology Counsel’s Small Business Innovation and Leadership Award. She is a Certified Public Accountant (inactive) in the state of Washington. Ms. Good received a Bachelor of Business Administration degree with a Concentration in Accounting from Pacific Lutheran University in 1987.
Positions
- Company NameTrevi Therapeutics, Inc.Stock CodeTRVIPositionCo-Founder, CEO, President, & DirectorColleagues
- DPDavid P. MeekerIndependent Chairman of the Board
- JVJames V. CassellaChief Development Officer
- FSFarrell SimonChief Commercial Officer
- TRThomas R. SciasciaCo-Founder & Chief Scientific Officer
- DCDavid C. HastingsChief Financial Officer & Principal Financial Officer
- MTMichael Thomas HeffernanIndependent Director
- AMAnne M. VanLentIndependent Director
- JBJeffrey BernhardMember of Clinical Advisory Board
